![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2019-11-20 Purchase | 2019-11-21 7:52 pm | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 15,000 | $0.34 | $5,100 | 15,000 (Indirect Direct) | View |
2020-08-21 Purchase | 2020-08-24 4:31 pm | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 30,000 | $0.69 | $20,700 | 50,000 (Indirect Direct) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2019-05-23 Option Award | 2019-05-28 4:10 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 150,000 | $1 | 150,000 (Direct) | View |
2019-05-23 Option Award | 2019-05-28 4:12 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 150,000 | $1 | 150,000 (Direct) | View |
2019-05-23 Option Award | 2019-05-28 4:14 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $1 | 150,000 (Direct) | View |
2019-05-23 Option Award | 2019-05-28 4:16 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 50,000 | $1 | 50,000 (Direct) | View |
2019-05-23 Option Award | 2019-05-28 4:17 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 50,000 | $1 | 50,000 (Direct) | View |
2019-05-23 Option Award | 2019-05-28 4:18 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 50,000 | $1 | 50,000 (Direct) | View |
2019-05-23 Option Award | 2019-05-28 4:20 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 50,000 | $1 | 50,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:00 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $1.41 | 75,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:00 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 75,000 | $1.41 | 75,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:00 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 75,000 | $1.41 | 75,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 75,000 | $1.41 | 75,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 300,000 | $1.41 | 300,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 175,000 | $1.41 | 175,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 100,000 | $1.41 | 100,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 100,000 | $1.41 | 100,000 (Direct) | View |
2019-10-21 Option Award | 2019-10-22 5:02 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $1.41 | 150,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $0.398 | 75,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 75,000 | $0.398 | 75,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 75,000 | $0.398 | 75,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 75,000 | $0.398 | 75,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 300,000 | $0.398 | 300,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $0.398 | 150,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 150,000 | $0.398 | 150,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $0.398 | 150,000 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 5:11 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 150,000 | $0.398 | 150,000 (Direct) | View |
2020-06-30 Option Award | 2020-07-01 5:20 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $0.448 | 30,375 (Direct) | View |
2020-06-30 Option Award | 2020-07-01 5:28 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 5,000 | $0.448 | 5,000 (Direct) | View |
2020-06-30 Option Award | 2020-07-01 5:33 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 5,000 | $0.448 | 5,000 (Direct) | View |
2020-06-30 Option Award | 2020-07-01 5:35 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 5,000 | $0.448 | 67,724 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:47 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 75,000 | $1.77 | 75,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:48 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 5,000 | $0.4521 | 150,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:48 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $1.77 | 150,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:51 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 150,000 | $1.77 | 150,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:52 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 75,000 | $1.77 | 75,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:54 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $1.77 | 75,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:55 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 5,000 | $0.4521 | 150,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:55 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 150,000 | $1.77 | 150,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:57 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 5,000 | $0.4521 | 150,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:57 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $1.77 | 150,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:58 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $0.4521 | 300,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:58 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 300,000 | $1.77 | 300,000 (Direct) | View |
2020-12-30 Option Award | 2021-01-04 4:59 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 75,000 | $1.77 | 75,000 (Direct) | View |